NCT05557006

Brief Summary

Conduction system pacing (CSP), including His bundle pacing (HBP) and left bundle branch (LBB) pacing (LBBP), as a physiological pacing strategy, can achieve interventricular and/or intra-left ventricular mechanical synchronization by delivering physiological or nearly physiological ventricular activation. And many studies have verifed clinical efficacy of CSP that it can significantly relieve dyssynchrony of ventricular contraction, improve cardiac function and reduce the risk of heart failure as compared to right ventricular pacing. However, CSP has some shortcomings which limit its widespread application to some extent. As for HBP, although it can achieve optimal physiological ventricular synchronization, the problems of relatively high pacing threshold, low R-wave amplitude, the long-term performance, and inability to correct infra-Hisian atrioventricular block and intraventricular block in some patients have always been concerns. Nevertheless, LBBP is likely free of the restrictions mentioned above. On the contrary, LBBP can capture the left conduction system by directly stimulating the proximal LBB distal to the site of conduction block, thereby achieving rapid and physiological LV activation with a lower and stable pacing threshold and higher R-wave amplitude. However, as a newly emerged physiologic pacing technology, LBBP is currently in the exploratory stage and there are some phenomena to be interpreted, such as the evolution of pacing QRS morphology during the lead penetration into the interventricular septum. Therefore, the aim of this study is to assess the morphological evolution and electrophysiological characteristics of various pacing QRS patterns observed as the lead penetrates the interventricular septum from right to left.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 19, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 27, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

September 27, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

March 16, 2023

Status Verified

March 1, 2023

Enrollment Period

1.6 years

First QC Date

September 19, 2022

Last Update Submit

March 15, 2023

Conditions

Keywords

Left Bundle Branch PacingLeft Bundle Branch Area PacingSeptal PacingLeft Ventricular Activation TimeRight Ventricular Activation Time

Outcome Measures

Primary Outcomes (3)

  • Left ventricular activation time (LVAT)

    Left ventricular activation time (LVAT) is defined as the interval from the onset of the pacing stimulus to the peak of the R wave in lead V5/6, which reflects the lateral precordial myocardium depolarization time.

    Continuous uninterrupted monitoring during the lead penetration into the interventricular septum.

  • Right ventricular activation time (RVAT)

    Right ventricular activation time (RVAT) is defined as the interval from the onset of the pacing stimulus to the peak potential recorded by the atrial electrode temporarily placed in the right ventricle, which reflects delayed right ventricular activation.

    Continuous uninterrupted monitoring during the lead penetration into the interventricular septum.

  • Paced QRS morphology

    Paced QRS morphology during lead penetration through the interventricular septum mainly includes left bundle branch block, intraventricular block and right bundle branch block.

    Continuous uninterrupted monitoring during the lead penetration into the interventricular septum.

Secondary Outcomes (3)

  • Stimulus-QRSend duration (s-QRSend)

    Continuous uninterrupted monitoring during the lead penetration into the interventricular septum.

  • The late-R wave duration and amplitude in lead V1 (r´dur、r´amp)

    Continuous uninterrupted monitoring during the lead penetration into the interventricular septum.

  • The S wave duration and amplitude in lead V6 (Sdur、Samp)

    Continuous uninterrupted monitoring during the lead penetration into the interventricular septum.

Study Arms (1)

All patients

Patients who meet the inclusion criteria

Procedure: left bundle branch pacing

Interventions

In the procedure of left bundle branch pacing, various QRS morphologies are observed as penetrating the lead into the interventricular septum.

All patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients requiring a high percentage of ventricular pacing (\>40% expected ventricular pacing) include patients with advanced or third-degree atrioventricular block and atrial fibrillation with bradycardia.

You may qualify if:

  • The indications for pacemaker implantation are in accordance with the 2021 European Society of Cardiology (ESC) guidelines.
  • Patients requiring a high percentage of ventricular pacing (\>40% expected ventricular pacing) include patients with advanced or third-degree atrioventricular block and atrial fibrillation with bradycardia.
  • Left bundle branch pacing will be performed.
  • Patients voluntarily participate and sign informed consent.

You may not qualify if:

  • Atrioventricular block caused by reversible factors such as acute myocardial infarction and electrolyte disturbance.
  • Patients with severe liver or renal failure.
  • Life expectancy \< 1 year.
  • Patients with age \< 18 years.
  • Left ventricular ejection fraction (LVEF) \< 40%.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

General Hospital of Northern Theater Command

Shenyang, Liaoning, 110016, China

RECRUITING

Related Publications (2)

  • Shimeno K, Tamura S, Nakatsuji K, Hayashi Y, Abe Y, Naruko T. Characteristics and proposed mechanisms of QRS morphology observed during the left bundle branch pacing procedure. Pacing Clin Electrophysiol. 2021 Dec;44(12):1987-1994. doi: 10.1111/pace.14382. Epub 2021 Oct 31.

    PMID: 34662435BACKGROUND
  • Zhang J, Sheng X, Pan Y, Wang M, Fu G. Electrophysiological Insights into Three Modalities of Left Bundle Branch Area Pacing in Patients Indicated for Pacing Therapy. Int Heart J. 2021 Jan 30;62(1):78-86. doi: 10.1536/ihj.20-490. Epub 2020 Dec 26.

    PMID: 33390564BACKGROUND

Study Officials

  • Yanchun Liang, MD、PhD

    The General Hospital of Northern Theater Command

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yanchun Liang, MD、PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

September 19, 2022

First Posted

September 27, 2022

Study Start

September 27, 2022

Primary Completion

May 1, 2024

Study Completion

May 1, 2024

Last Updated

March 16, 2023

Record last verified: 2023-03

Locations